Salt Lake-based NPS Pharmaceuticals said Tuesday that Dr. N. Anthony Coles has been appointed president and chief operating officer.
Coles joins NPS from Vertex Pharmaceuticals, where he was senior vice president of commercial operations and, previously, also had responsibility for global corporate and business development. He also has worked at Bristol-Myers Squibb and Merck & Co.
Coles, 45, will report to NPS chief executive Hunter Jackson, whom he will succeed as CEO in approximately six months when Jackson plans to step down from that position but remain a director of the company, NPS said.
Jackson founded NPS in 1986 and has served as its chairman and CEO since then.